202 related articles for article (PubMed ID: 22747490)
41.
Paparella AS; Cahill SM; Aboulache BL; Schramm VL
ACS Chem Biol; 2022 Sep; 17(9):2507-2518. PubMed ID: 36038138
[TBL] [Abstract][Full Text] [Related]
42. Identification of Oligosaccharides in Human Milk Bound onto the Toxin A Carbohydrate Binding Site of Clostridium difficile.
Nguyen TT; Kim JW; Park JS; Hwang KH; Jang TS; Kim CH; Kim D
J Microbiol Biotechnol; 2016 Apr; 26(4):659-65. PubMed ID: 26718473
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
[TBL] [Abstract][Full Text] [Related]
44. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
45. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
Chen B; Liu Z; Perry K; Jin R
Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
[TBL] [Abstract][Full Text] [Related]
46. The distribution and density of Clostridium difficile toxin receptors on the intestinal mucosa of neonatal pigs.
Keel MK; Songer JG
Vet Pathol; 2007 Nov; 44(6):814-22. PubMed ID: 18039894
[TBL] [Abstract][Full Text] [Related]
47. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
48. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells.
Gerhard R; Nottrott S; Schoentaube J; Tatge H; Olling A; Just I
J Med Microbiol; 2008 Jun; 57(Pt 6):765-770. PubMed ID: 18480335
[TBL] [Abstract][Full Text] [Related]
49. Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.
Sturino JM; Pokusaeva K; Carpenter R
Antimicrob Agents Chemother; 2015 Dec; 59(12):7178-83. PubMed ID: 26149988
[TBL] [Abstract][Full Text] [Related]
50. Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain.
Gerhard R; Frenzel E; Goy S; Olling A
J Med Microbiol; 2013 Sep; 62(Pt 9):1414-1422. PubMed ID: 23558138
[TBL] [Abstract][Full Text] [Related]
51. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile.
Elliott B; Reed R; Chang BJ; Riley TV
Anaerobe; 2009 Dec; 15(6):249-51. PubMed ID: 19723585
[TBL] [Abstract][Full Text] [Related]
52. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
53. Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases.
Busch C; Hofmann F; Gerhard R; Aktories K
J Biol Chem; 2000 May; 275(18):13228-34. PubMed ID: 10788427
[TBL] [Abstract][Full Text] [Related]
54. Adaptation of Clostridium difficile toxin A for use as a protein translocation system.
Kern SM; Feig AL
Biochem Biophys Res Commun; 2011 Feb; 405(4):570-4. PubMed ID: 21266163
[TBL] [Abstract][Full Text] [Related]
55. [Laboratory-based evaluation of TOX A/B QUIK CHEK "NISSUI" to detect toxins A and B of clostridium difficile].
Nakasone I; Shiohira CM; Yamane N
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2007; 18(2):109-16. PubMed ID: 18154439
[TBL] [Abstract][Full Text] [Related]
56. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
[TBL] [Abstract][Full Text] [Related]
57. Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis.
Jank T; Reinert DJ; Giesemann T; Schulz GE; Aktories K
J Biol Chem; 2005 Nov; 280(45):37833-8. PubMed ID: 16157585
[TBL] [Abstract][Full Text] [Related]
58. Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity.
Stroke IL; Letourneau JJ; Miller TE; Xu Y; Pechik I; Savoly DR; Ma L; Sturzenbecker LJ; Sabalski J; Stein PD; Webb ML; Hilbert DW
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483125
[No Abstract] [Full Text] [Related]
59. The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A.
Olling A; Goy S; Hoffmann F; Tatge H; Just I; Gerhard R
PLoS One; 2011 Mar; 6(3):e17623. PubMed ID: 21445253
[TBL] [Abstract][Full Text] [Related]
60. Effects of Clostridium difficile Toxin A on the proteome of colonocytes studied by differential 2D electrophoresis.
Zeiser JJ; Klodmann J; Braun HP; Gerhard R; Just I; Pich A
J Proteomics; 2011 Dec; 75(2):469-79. PubMed ID: 21890007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
